CCO 2021 Global Conference Coverage: Gynecologic Cancer Updates

The 2021 SGO Virtual Annual Meeting, 19-25 March 2021, in Seattle, Washington, USA; The 2021 ASCO Annual Meeting, 4-8 June 2021, in Chicago, Illinois, USA; The 2021 IGCS Meeting, 30 August - 2 September, in Rome, Italy; The ESMO 2021 Annual Congress, 17-21 September 2021, in Paris, France; The 2021 ESGO Conference, 23-26 October 2021, in Prague, Czech Republic

Download this “living” summary slideset covering new data from key studies in gynecologic cancers as they are presented at different conferences throughout 2021.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Jubilee Brown, MD
Nicole Concin, MD, PhD
Bernard Doger de Spéville, MD, PhD
Melissa M. Hardesty, MD, MPH
person default
Alexandra Leary, MD, PhD
Domenica Lorusso, MD, PhD
Ursula Matulonis, MD
David Scott Miller, MD, FACOG, FACS
Prof Isabelle Ray-Coquard, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.46 MB
Released: November 15, 2021

Acknowledgements

This educational activity is supported by an educational grant from
GlaxoSmithKline

Related Content

Expert commentary on HRD testing, PARP inhibitor, and quality-of-life studies in rare ovarian cancer from the 2022 ESGO Congress, from Clinical Care Options (CCO)

Prof Isabelle Ray-Coquard, MD, PhD Ignace Vergote, MD, PhD Released: December 2, 2022

Experts provide their thoughts on key data in breast, gynecologic, renal cell, urothelial, lung, hepatobiliary, and skin cancers presented at the 2022 ESMO Congress, from Clinical Care Options (CCO)

Nicoletta Colombo, MD Robert Motzer, MD person default Sapna P. Patel, MD David Planchard, MD, PhD Elizabeth R. Plimack, MD, MS Rachna Shroff, MD Sara Tolaney, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: November 14, 2022 Expired: November 13, 2023

Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2022, from Clinical Care Options (CCO)

Susana Banerjee, MBBS, MA, PhD, FRCP Jubilee Brown, MD person default Elisabeth Diver, MD person default Alexandra Leary, MD, PhD Domenica Lorusso, MD, PhD David Scott Miller, MD, FACOG, FACS person default Mansoor Raza Mirza, MD Prof Isabelle Ray-Coquard, MD, PhD Angeles Alvarez Secord, MD, MHSc Ignace Vergote, MD, PhD Released: November 10, 2022

Expert commentary on new clinical trial data in cervical cancer and ovarian cancer, from Clinical Care Options (CCO)

Susana Banerjee, MBBS, MA, PhD, FRCP person default Mansoor Raza Mirza, MD Released: November 3, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings